These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 25455560)
1. Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium. Bharatwaj B; Mohammad AK; Dimovski R; Cassio FL; Bazito RC; Conti D; Fu Q; Reineke J; da Rocha SR Mol Pharm; 2015 Mar; 12(3):826-38. PubMed ID: 25455560 [TBL] [Abstract][Full Text] [Related]
2. Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers. Heyder RS; Zhong Q; Bazito RC; da Rocha SRP Int J Pharm; 2017 Mar; 520(1-2):181-194. PubMed ID: 28161666 [TBL] [Abstract][Full Text] [Related]
3. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers. Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811 [TBL] [Abstract][Full Text] [Related]
4. Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblends. Bharatwaj B; Dimovski R; Conti DS; da Rocha SR AAPS J; 2014 May; 16(3):522-38. PubMed ID: 24691741 [TBL] [Abstract][Full Text] [Related]
5. Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution. Zhong Q; Merkel OM; Reineke JJ; da Rocha SR Mol Pharm; 2016 Jun; 13(6):1866-78. PubMed ID: 27148629 [TBL] [Abstract][Full Text] [Related]
6. PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations. Yang L; da Rocha SR Mol Pharm; 2014 May; 11(5):1459-70. PubMed ID: 24679335 [TBL] [Abstract][Full Text] [Related]
7. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia. Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255 [TBL] [Abstract][Full Text] [Related]
8. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
9. Ultrafast in situ forming poly(ethylene glycol)-poly(amido amine) hydrogels with tunable drug release properties via controllable degradation rates. Buwalda SJ; Bethry A; Hunger S; Kandoussi S; Coudane J; Nottelet B Eur J Pharm Biopharm; 2019 Jun; 139():232-239. PubMed ID: 30954658 [TBL] [Abstract][Full Text] [Related]
10. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers. Bielski ER; Zhong Q; Brown M; da Rocha SR Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804 [TBL] [Abstract][Full Text] [Related]
11. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. Kaminskas LM; Kota J; McLeod VM; Kelly BD; Karellas P; Porter CJ J Control Release; 2009 Dec; 140(2):108-16. PubMed ID: 19686787 [TBL] [Abstract][Full Text] [Related]
12. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195 [TBL] [Abstract][Full Text] [Related]
13. A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep. Ryan GM; Bischof RJ; Enkhbaatar P; McLeod VM; Chan LJ; Jones SA; Owen DJ; Porter CJ; Kaminskas LM Pharm Res; 2016 Feb; 33(2):510-25. PubMed ID: 26486513 [TBL] [Abstract][Full Text] [Related]
14. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Li Y; He H; Jia X; Lu WL; Lou J; Wei Y Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent. Ryan GM; Kaminskas LM; Kelly BD; Owen DJ; McIntosh MP; Porter CJ Mol Pharm; 2013 Aug; 10(8):2986-95. PubMed ID: 23750747 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin. Bai S; Ahsan F Pharm Res; 2009 Mar; 26(3):539-48. PubMed ID: 19034631 [TBL] [Abstract][Full Text] [Related]
17. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biodistribution, and imaging of PEGylated-acetylated polyamidoamine dendrimers. Liu J; Liu J; Chu L; Tong L; Gao H; Yang C; Wang D; Shi L; Kong D; Li Z J Nanosci Nanotechnol; 2014 May; 14(5):3305-12. PubMed ID: 24734545 [TBL] [Abstract][Full Text] [Related]
19. PEGylated nanocarriers for systemic delivery. Jain NK; Nahar M Methods Mol Biol; 2010; 624():221-34. PubMed ID: 20217599 [TBL] [Abstract][Full Text] [Related]